Prothena to Participate in the H.C. Wainwright 28th Annual Global Investment ConferenceBusiness Wire • 09/09/26
PRTA's Q2 Loss Narrower Than Expected, Pipeline Progress in FocusZacks Investment Research • 08/07/26
Prothena Reports Second Quarter 2026 Financial Results and Business HighlightsBusiness Wire • 08/06/26
Prothena Posts Q1 Earnings as Revenues Surge on Milestone PaymentZacks Investment Research • 05/08/26
Prothena Reports First Quarter 2026 Financial Results and Business HighlightsBusiness Wire • 05/07/26
Prothena Announces Novo Nordisk Obtains Fast Track Designation from the U.S. FDA for Coramitug (PRX004) in ATTR Amyloidosis with CardiomyopathyBusiness Wire • 04/27/26
Wall Street Analysts Think Prothena (PRTA) Could Surge 120.19%: Read This Before Placing a BetZacks Investment Research • 03/26/26
Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson's and Alzheimer's Disease at AD/PD™ 2026Business Wire • 03/21/26
Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with CardiomyopathyBusiness Wire • 03/09/26
Wall Street Analysts Believe Prothena (PRTA) Could Rally 118.09%: Here's is How to TradeZacks Investment Research • 03/03/26